Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Net Debt / EBITDA

Amag Pharmaceuticals Net Debt / EBITDA Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Net Debt / EBITDA from 2010 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Amag Pharmaceuticals Net Debt / EBITDA for the quarter ending June 06, 2020 was $-4m a 46.53% decrease of -2m year over year
  • Amag Pharmaceuticals Net Debt / EBITDA for the last 12 months ending June 06, 2020 was $-2m a 60.77% decrease of -1m year over year
  • Amag Pharmaceuticals Annual Net Debt / EBITDA for 2019 was $-1m a 3.98% decrease of 0m from 2018
  • Amag Pharmaceuticals Annual Net Debt / EBITDA for 2018 was $-1m a 331.45% decrease of -4m from 2017
  • Amag Pharmaceuticals Annual Net Debt / EBITDA for 2017 was $3m a 31.62% increase of 1m from 2016
Other Ratios Metrics:
  • Amag Pharmaceuticals Total Debt / Capital for the quarter ending September 09, 2018 was $27m a -79.63% decrease of -21m year over year
  • Amag Pharmaceuticals Other Liabilities for the quarter ending December 12, 2018 was $1m a -3,223.97% decrease of -46m year over year
  • Amag Pharmaceuticals Total Debt / Equity for the quarter ending September 09, 2018 was $37m a -153.66% decrease of -56m year over year
View Chart On Koyfin

Quarterly AMAG Net Debt / EBITDA Data

06/2020$-4m
03/2020$-3m
12/2019$-1m
09/2019$-2m
06/2019$0m
03/2019$0m
12/2018$2m
09/2018$-1m
06/2018$2m
03/2018$3m

Annual AMAG Net Debt / EBITDA Data

2019$-1m
2018$-1m
2017$3m
2016$2m
2015$3m
2014$23m
2013$39m
2012$20m
2011$3m
2010$3m